Cargando…

Matrix metalloproteinases in subjects with type 1 diabetes

BACKGROUND: Nephropathy is serious complication of diabetes. We have previously shown that level of the proteoglycan syndecan-1 in blood is associated with ultrastructural kidney changes in young persons with type 1 diabetes. Dysregulation of matrix metalloproteinases (MMPs) and tissue inhibitors of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gharagozlian, Sedegheh, Svennevig, Katja, Bangstad, Hans-Jacob, Winberg, Jan-Olof, Kolset, Svein Olav
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753592/ https://www.ncbi.nlm.nih.gov/pubmed/19758433 http://dx.doi.org/10.1186/1472-6890-9-7

Ejemplares similares

Systemic immune profile in Prader-Willi syndrome: elevated matrix metalloproteinase and myeloperoxidase and reduced macrophage inhibitory factor
por: Hope, Sigrun, et al.
Publicado: (2023)

Effect of inulin-type fructans on appetite in patients with type 2 diabetes: a randomised controlled crossover trial
por: Birkeland, Eline, et al.
Publicado: (2021)

Prebiotic effect of inulin-type fructans on faecal microbiota and short-chain fatty acids in type 2 diabetes: a randomised controlled trial
por: Birkeland, Eline, et al.
Publicado: (2020)

Correction to: Prebiotic effect of inulin‑type fructans on faecal microbiota and short‑chain fatty acids in type 2 diabetes: a randomised controlled trial
por: Birkeland, Eline, et al.
Publicado: (2020)

Short-chain fatty acids as a link between diet and cardiometabolic risk: a narrative review
por: Birkeland, Eline, et al.
Publicado: (2023)

Urine Levels of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Children with Type 1 Diabetes Mellitus
por: Yürük Yıldırım, Zeynep, et al.
Publicado: (2019)

Glucosamine exposure reduces proteoglycan synthesis in primary human endothelial cells in vitro
por: Reine, Trine M., et al.
Publicado: (2016)

Editorial: Growth and Tissue Regeneration with focus on Proteoglycans
por: Pedersen, Mona Elisabeth, et al.
Publicado: (2023)

Biosynthesis of Promatrix Metalloproteinase-9/Chondroitin Sulphate Proteoglycan Heteromer Involves a Rottlerin-Sensitive Pathway
por: Malla, Nabin, et al.
Publicado: (2011)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Dietary aspects related to health and obesity in Williams syndrome, Down syndrome, and Prader–Willi syndrome
por: Nordstrøm, Marianne, et al.
Publicado: (2015)

Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissuenhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase
por: Collins, H M, et al.
Publicado: (2001)

Matrix Metalloproteinases in Diabetic Kidney Disease
por: Garcia-Fernandez, Nuria, et al.
Publicado: (2020)

Gene Polymorphism of Matrix Metalloproteinase 9 in Asthenozoospermic Male Subjects
por: Mohagheghi, Sina, et al.
Publicado: (2018)

Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression.
por: Hur, J. H., et al.
Publicado: (2000)

Intellectual disability and nutrition‐related health
por: Kolset, Svein O
Publicado: (2020)

Securing rights and nutritional health for persons with intellectual disabilities – a pressing challenge
por: Kolset, Svein Olav, et al.
Publicado: (2018)

Syndecan-4(–/–) Mice Have Smaller Muscle Fibers, Increased Akt/mTOR/S6K1 and Notch/HES-1 Pathways, and Alterations in Extracellular Matrix Components
por: Rønning, Sissel Beate, et al.
Publicado: (2020)

Increased Expressions of Matrix Metalloproteinases (MMPs) in Prostate Cancer Tissues of Men with Type 2 Diabetes
por: Franko, Andras, et al.
Publicado: (2020)

Matrix metalloproteinases in arthritic disease
por: Murphy, Gillian, et al.
Publicado: (2002)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Coordinated elevation of membrane type 1-matrix metalloproteinase and matrix metalloproteinase-2 expression in rat uterus during postpartum involution
por: Manase, Kengo, et al.
Publicado: (2006)

Membrane Localization of Membrane Type 1 Matrix Metalloproteinase by CD44 Regulates the Activation of Pro-Matrix Metalloproteinase 9 in Osteoclasts
por: Chellaiah, Meenakshi A., et al.
Publicado: (2013)

Effect of advanced glycation end products, extracellular matrix metalloproteinase inducer and matrix metalloproteinases on type-I collagen metabolism
por: LI, WANG, et al.
Publicado: (2016)

Tissue inhibitor matrix metalloproteinase 1 and risk of type 2 diabetes in a Chinese population
por: Wang, Yeli, et al.
Publicado: (2020)

Matrix metalloproteinases and epileptogenesis
por: Ikonomidou, Chrysanthy
Publicado: (2014)

Matrix Metalloproteinases and Glaucoma
por: Kim, Moo Hyun, et al.
Publicado: (2022)

Low density lipoprotein from patients with Type 2 diabetes increases expression of monocyte matrix metalloproteinase and ADAM metalloproteinase genes
por: Worley, Joanna R, et al.
Publicado: (2007)

Tumor Necrosis Factor-α, Matrix-Metalloproteinases 8 and 9 Levels in the Saliva Are Associated with Increased Hemoglobin A1c in Type 1 Diabetes Subjects
por: Kuehl, Melanie N., et al.
Publicado: (2015)

Proteases in Plasma and Kidney of db/db Mice as Markers of Diabetes-Induced Nephropathy
por: Hadler-Olsen, E., et al.
Publicado: (2011)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Effects of reduced β(2)-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice
por: Xu, Jun, et al.
Publicado: (2014)

Knockout of Matrix Metalloproteinase 2 Opposes Hypertension- and Diabetes-induced Nephropathy
por: Hirata, Takashi, et al.
Publicado: (2023)

Matrix metalloproteinases in type 2 diabetes and non-diabetic controls: effects of short-term and chronic hyperglycaemia
por: Lewandowski, Krzysztof C., et al.
Publicado: (2011)

Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies
por: Peeters, Stijn A., et al.
Publicado: (2017)

Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma
por: Štrbac, Danijela, et al.
Publicado: (2017)

Erratum: Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery
por: Bojic, Suzana, et al.
Publicado: (2018)

Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma
por: Kikuchi, R, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_is087lcgrpvv1ogujms8cfsukf